Apolipoprotein E4 genotype increases the risk of postoperative cognitive dysfunction in patients undergoing coronary artery bypass graft surgery

Journal of Cardiovascular Surgery

Volumn 47, Issue 4, 2006, Pages 451-456

  Lelis, R G B ^a   Krieger, J E ^a   Pereira, A C ^a   Schmidt, A P ^a   Carmona, M J ^a   Oliveira, S A ^a   Auler Jr , J O C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apolipoproteins; Cardiopulmonary bypass; Heart, surgery; Postoperative cognitive dysfuntion

Indexed keywords

APOLIPOPROTEIN E4; CREATININE; DNA; GLUCOSE;

ADULT; AGED; ALLELE; ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; COGNITION; COGNITIVE DEFECT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; ELECTIVE SURGERY; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GLASGOW COMA SCALE; HEART SURGERY; HETEROZYGOTE; HIGH RISK PATIENT; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MINI MENTAL STATE EXAMINATION; MORBIDITY; OBSERVATIONAL STUDY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; SAMPLE; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COGNITION DISORDERS; CORONARY ARTERY BYPASS; CORONARY DISEASE; DNA; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS;

EID: 33749061069     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Rasmussen LS, Larsen K, Houx P, Skovgaard LT, Hanning CD, Moller JT. The assessment of postoperative cognitive function. Acta Anaesthesiol Scand 2001;45:275-89.
2. Newman MF, Croughwell ND, Blumenthal JA, Lowry E, White WD, Spillane W et al. Predictors of cognitive decline after cardiac operation. Ann Thorac Surg 1995;59:1326-30.
3. Arrowsmith JE, Grocott HP, Reves JG, Newman MF. Central nervous system complications of cardiac surgery. Br J Anaesth 2000;84:378-93.
4. Weisgraber KH. Apolipoprotein E: structure-function relationships. Adv Protein Chem 1994;45:249-302.
5. Laskowitz DT, Lee DM, Schmechel D, Staats HF. Altered immune responses in apolipoprotein E-deficient mice. J Lipid Res 2000;41:613-20.
6. Lindahl G, Mailly F, Humphries S, Seed M. Apolipoprotein E phenotype and lipoprotein(a) in familial hypercholesterolaemia: implication for lipoprotein(a) metabolism. Clin Invest 1994;72:631-8.
7. Albert MS. Cognitive and neurobiologic markers of early Alzheimer disease. Proc Natl Acad Sci USA 1996;93:13547-51.
8. Gaynor JW, Gerdes M, Zackai EH. Apolipoprotein E genotype and neurodevelopmental sequelae of infant cardiac surgery. J Thorac Cardiovasc Surg 2003;126:1736-45.
9. Tardiff BE, Newman MF, Saunders AM, Strittmatter WJ, Blumenthal JA, White WD et al. Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. Ann Thorac Surg 1997;64:715-20.
10. Steed L, Kong R, Stygall J, Acharya J, Bolla M, Harrison MJ et al. The role of apolipoprotein E in cognitive decline after cardiac operation. Ann Thorac Surg 2001;71:823-6.
11. Grocott HP, Newman MF, El-Moalem H, Bainbridge D, Butler A, Laskowitz DT. Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass. J Thorac Cardiovasc Surg 2001;122:622-3.
12. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
13. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2:81-4.
14. Bertolucci PH, Brucki SM, Campacci SR, Juliano Y. [The Mini-Mental State Examination in a general population: influence of education status] Arq Neuropsiquiatr 1994;52:1-7. Portuguese.
15. Anthony JC, Le Resche L, Niaz U, Von Korff MR, Folstein MF. Limits of the Mini-Mental State as a screening test for dementia and delirium among hospital patients. Psychol Med 1982;12:397-408.
16. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72.
17. Wolman RL, Nussmeier NA, Aggarwal A, Kanchuger MS, Roach GW, Newman MF et al. Cerebral injury after cardiac surgery: identification of a group at extraordinary risk. Multicenter Study of Perioperative Ischemia Research Group (McSPI) and the Ischemia Research Education Foundation (IREF) Investigators. Stroke 1999;30:514-22.
18. Roach GW, Kanchuger M, Mangano MC, Newman M, Nussmeier N, Wolman R et al. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med 1996;335:1857-63.
19. Newman MF, Kramer D, Croughwell ND, Sanderson I, Blumenthal JA, White WD et al. Differential age effects of mean arterial pressure and rewarming on cognitive dysfunction after cardiac surgery. Anesth Analg 1995;81:236-42.
20. Croughwell ND, Newman MF, Blumenthal JA, White WD, Lewis JB, Frasco PE et al. Jugular bulb saturation and cognitive dysfunction after cardiopulmonary bypass. Ann Thorac Surg 1994;58:1702-8.
21. Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 2001;344: 395-402.
22. Taggart DP, Browne SM, Halligan PW, Wade DT. Is cardiopulmonary bypass still the cause of cognitive dysfunction after cardiac operations. J Thorac Cardiovasc Surg 1999;118:414-20.
23. Benedict RH. Cognitive function after open-heart surgery: are postoperative neuropsychological deficits caused by cardiopulmonary bypass? Neuropsychol Rev 1994;4:223-55.
24. Ti LK, Mathew JP, Mackensen GB, Grocott HP, White WD, Reves JG et al. Effect of apolipoprotein E genotype on cerebral autoregulation during cardiopulmonary bypass. Stroke 2001;32:1514-9.
25. Drabe N, Zund G, Grunenfelder J, Sprenger M, Hoerstrup SP, Bestmann L et al. Genetic predisposition in patients undergoing cardiopulmonary bypass surgery is associated with an increase of inflammatory cytokines. Eur J Cardiothorac Surg 2001;20: 609-13.
26. Zamvar V, Williams D, Hall J, Payne N, Cann C, Young K et al. Assessment of neurocognitive impairment after off-pump and on-pump techniques for coronary artery bypass graft surgery: Prospective randomized controlled trial. BMJ 2002;325:1268-72.
27. Van Dijk D, Jansen EW, Hijman R, Nierich AP, Diephuis JC, Moons KG et al. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a randomized trial. JAMA 2002;287:1405-12.
28. Robson MJA, Alston RP, Andrews PJ, Wenham PR, Souter MJ, Deary IJ. Apolipoprotein E and neurocognitive outcome from coronary artery bypass surgery. J Neurol Neurosurg Psychiatry 2002;72:675-6.
29. Kofke WA, Konitzer P, Meng QC, Guo J, Cheung A. The effect of apolipoprotein E genotype on neuron specific enolase and S100, levels after cardiac surgery. Anesth Analg 2004;99:1323-5.
30. Marangos PJ, Schmechel DE. Neuron-specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Ann Rev Neurol Sci 1987;10:269-95.
31. Georgiadis D, Berger A, Kowatschev E, Lautenschlager C, Borner A, Lindner A et al. Predictive value of S100, and neuron specific enolase serum levels for adverse neurologic outcome after surgery. J Thorac Cardiovasc Surg 2000;119:138-47.
32. Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 1998;351:857-61.
33. Williams-Russo P, Sharrock NE, Mattis S, Szatrowski TP, Charlson ME. Cognitive effects after epidural vs general anesthesia in older adults: a randomized trial. JAMA 1995;274:44-50.
34. Abildstrom H, Christiansen M, Siersma VD, Rasmussen LS. Apolipoprotein E genotype and cognitive dysfunction after noncardiac surgery. Anesthesiology 2004;101:855-61.
35. Folks DG, Franceschini J, Sokol RS, Freeman AM, Folks DM. Coronary artery bypass surgery in older patients: psychiatric morbidity. South Med J 1986;79:303-6.
36. Grimm M, Yeganehfar W, Laufer G, Madl C, Kramer L, Eisenhuber E et al. Cyclosporine may affect improvement of cognitive brain function after successful cardiac transplantation. Circulation 1996;94:1339-45.
37. Kilo J, Czerny M, Gorlitzer M, Zimpfer D, Baumer H, Wolner E et al. Cardiopulmonary bypass affects cognitive brain function after coronary artery bypass grafting. Ann Thorac Surg 2001;72:1926-72.
38. Kishikawa K, Kamouchi M, Okada Y, Inoue T, Ibayashi S, Iida M. Effects of carotid endarterectomy on cerebral blood flow and neuropsychological test performance in patients with high-grade carotid stenosis. J Neurol Sci 2003;213:19-24.
39. Von Knobelsdorff G, Hoppner RM, Tonner PH, Paris A, Nienaber CA, Scholz J et al. Induced arterial hypotension for interventional thoracic aortic stent-graft placement: impact on intracranial haemodynamics and cognitive function. Eur J Anesthesiol 2003;20:134-40.